Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 4
1(14.3%)
7Total
N/A(6)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07553702Not ApplicableActive Not Recruiting

Dance Intervention in Breast Cancer Treatment

Role: lead

NCT07493655Not ApplicableNot Yet Recruiting

Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis

Role: lead

NCT05873296Not ApplicableCompleted

Health Education for Women With Breast Cancer

Role: lead

NCT03061773Not ApplicableCompleted

Physical Training on Patients With Breast Cancer

Role: lead

NCT02641210Phase 4Completed

Impact of Periodontal Treatment on Serum Levels of Hepcidin and Hemoglobin

Role: lead

NCT02584712Not ApplicableCompleted

Effect of Exercise Training in Autonomic Modulation in Breast Cancer Patients

Role: lead

NCT01794910Not ApplicableCompleted

A Randomized Controlled Trial Comparing the Effect of Pelvic Floor Muscle Training

Role: collaborator

All 7 trials loaded